Home Biosimilar Antibodies Immunology & Inflammation Complement System antibody Lendalizumab (Anti-Complement C5) For research use only.
Not for use in humans.

Lendalizumab (Anti-Complement C5)

Synonyms: ALXN1007, Olendalizumab

Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.

Lendalizumab (Anti-Complement C5)

Purity & Quality Control

≥99

Choose Selective Complement System Inhibitors

Biological Activity

Description Lendalizumab (Anti-Complement C5) is a proprietary antibody that targets the complement protein C5a with potential immunomodulating and anti-inflammatory activities. MW : 146.02 KD.

Product Details

CAS No. 2210314-30-8
Molecular Weight 146.02
Isotype Human IgG2SA
Source CHO
Purification AKTA
Sterility 0.2 μM filtered
Formulation 100mMPro-Ac,20mMArg-Ac，pH5.0
Storage
(From the date of receipt)		 Store the undiluted solution at -20°C in the dark to avoid freeze-thaw cycles.

Tech Support

If you have any other enquiries, please leave a message.

* Indicates a Required Field

Please enter your name.
Please enter your email. Please enter a valid email address.
Please write something to us.
Tags: buy Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) supplier | purchase Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) cost | Lendalizumab (Anti-Complement C5) manufacturer | order Lendalizumab (Anti-Complement C5) | Lendalizumab (Anti-Complement C5) distributor